Filing Details
- Accession Number:
- 0001127602-19-003835
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-02-04 17:41:47
- Reporting Period:
- 2019-01-31
- Accepted Time:
- 2019-02-04 17:41:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1705843 | Calyxt Inc. | CLXT | Agricultural Chemicals (2870) | 271967997 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1712191 | F Daniel Voytas | 2800 Mount Ridge Road Roseville MN 55113 | Chief Science Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-01-31 | 4,083 | $3.71 | 97,065 | No | 4 | M | Direct | |
Common Stock | Disposition | 2019-01-31 | 4,083 | $13.00 | 92,982 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2019-02-01 | 4,087 | $3.71 | 97,069 | No | 4 | M | Direct | |
Common Stock | Disposition | 2019-02-01 | 4,087 | $13.00 | 92,982 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2019-01-31 | 4,083 | $0.00 | 4,083 | $3.71 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2019-02-01 | 4,087 | $0.00 | 4,087 | $3.71 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
8,170 | 2024-12-03 | No | 4 | M | Direct | |
4,083 | 2024-12-03 | No | 4 | M | Direct |
Footnotes
- Includes 85,443 restricted stock units with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017 and remain unvested; 15,078 shares will vest on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.
- The stock option to purchase shares of Calyxt, Inc. common stock ("Stock Option") was granted on December 3, 2014 and vested 20% on January 3, 2015 and 20% on April 10, 2015, with the remainder vested quarterly in equal installments thereafter, 15% of which vested immediately on July 25, 2017 when Calyxt, Inc. underwent its initial public offering.